Press Release

Innovation Zed, a pioneering developer of connected add-on devices for drug delivery devices and, Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, today announced a strategic partnership to develop and deploy digital companion apps with the adaptive DOSE platform hardware add-on technology for injectable therapies.

Innovation Zed, a leading Irish R&D company specialising in innovative medical devices, announces its strategic partnership with Enhance-D, a Swiss company dedicated to enhancing diabetes and exercise management through its digital health platform.

Innovation Zed has partnered with GluCare.Health, a leading metabolic disease management platform, to provide connected insulin pen technology as part of a combination product in GluCare.Health's digital clinic ecosystem.

Innovation Zed, an Irish R&D company specialising in the design, development and manufacturing of medical technologies, announced today it has secured a CE Mark for the InsulCheck DOSE add-on device.

Innovation Zed, an Irish MedTech R&D company, today announced the signing of a global partnership and data integration agreement for its family of insulin pen 'add-on' devices with SNAQ.

Innovation Zed, developer of novel diabetes management technologies (the InsulCheck range), headquartered at NovaUCD, at University College Dublin, Ireland are delighted to announce today the arrival of the much anticipated InsulCheck DOSE technology that will be coming to market in 2022.

Innovation Zed Ltd., developer of novel diabetes technologies, announced further advancement in their research of technologies for non-invasive Continuous Glucose Monitoring and a new researcher to this project, Dr Rui Wu.

Innovation Zed Ltd. and A. Menarini Diagnostics, part of the Menarini Group, Enter Commercial Agreement for International Distribution of Innovative Insulin Pen “InsulCheck Connect” device

Irish medtech company Innovation Zed has announced the signing of a global partnership and data integration agreement for its family of insulin pen ‘add-on’ devices with UK-based GlucoRx.